A Phase II, Randomized, Comparative, Observer-Blind, Multi-Center Study Evaluating the Safety and Immunogenicity of the Liquid Formulation of Group B Streptococcus Trivalent Vaccine and of the Lyophilized Formulation of Group B Streptococcus Trivalent Vaccine in Healthy Non-Pregnant Women Aged 18 to 40 Years
Phase of Trial: Phase II
Latest Information Update: 01 Aug 2017
At a glance
- Drugs Streptococcal B vaccine conjugate (Primary) ; Streptococcal B vaccine conjugate
- Indications Streptococcal infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline; Novartis Vaccines
- 16 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Jul 2015 Planned End Date changed from 1 Oct 2015 to 1 Sep 2015 as reported by ClinicalTrials.gov record.
- 17 Mar 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record..